CTI BioPharma Corp. announced that Michael A. Metzger has been appointed a Director of CTI BioPharma. Mr. Metzger brings extensive experience leading and growing companies in the biopharmaceutical industry over the last 20 years. Mr. Metzger is currently president and chief operating officer of Syndax Pharmaceuticals, Inc. Mr. Metzger served as president and chief executive officer of Regado Biosciences Inc. from 2013 to 2015, where he oversaw the company's successful merger with Tobira Therapeutics Inc. in 2015 and acted as an advisor to Tobira during its subsequent sale to Allergan in 2016.